Suchergebnisse - "Allegra, Andrea Gaetano"

PubPharm (36)

1

Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2024

von Nicosia, L. | Ravelli, P. | Rigo, M. | +7

2

Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer : A Randomized Phase II Trial (ARTO)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Francolini, G. | Allegra, A. | Detti, B. | +33

3

Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736)

enthalten in: Cancers | 2023

von Francolini, G. | Garlatti, P. | Di Cataldo, V. | +20

4

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors : a preliminary, multicentre experience

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2022

von Francolini, G. | Campi, R. | Di Cataldo, V. | +20

5

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience

enthalten in: Clinical and translational oncology | 2022

von Francolini, G. | Campi, R. | Di Cataldo, V. | +20

6

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents : interim analysis of PRIMERA trial (NCT04188275)

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Francolini, G. | Loi, M. | Ciccone, L. | +20

7

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275)

enthalten in: Medical oncology | 2022

von Francolini, G. | Loi, M. | Ciccone, L. | +20

8

Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275)

enthalten in: Medical oncology | 2022

von Francolini, G. | Loi, M. | Ciccone, L. | +20

9

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy : a study on 18 patients with multiple myeloma

enthalten in: Archives of medical science : AMS | 2022

von Allegra, A. | Rizzo, V. | Innao, V. | +9

10

SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma

enthalten in: Clinical biochemistry | 2021

von Allegra, A. | Innao, V. | Polito, F. | +7